Biosynthesis of Cannabinoids Market Size, Share, Growth, and Industry Analysis, By Type (THC & CBD), By Application (Food Industry & Medical Industry), and Regional Forecast to 2032

Last Updated: 04 January 2025

BIOSYNTHESIS OF CANNABINOIDSMARKET OVERVIEW

The global Biosynthesis of Cannabinoids market size expanded rapidly XX  in 2023 and is projected to grow substantially XX by 2032, exhibiting a prodigious CAGR XX during the forecast period.

The Biosynthesis of Cannabinoids Market is a new, upcoming domain of the production of cannabinoids using microbiological systems like yeasts and bacteria and not on the conventional large-scale farming of plants. It makes this approach cheaper, reproductive, and uniform and fits pharmaceuticals, cosmetics, and food industries’ cannabinoid production needs. Rising applications for cannabinoids, an increase in demand, and improvement in the field of synthetic biology are some of the factors that are driving the market growth. Individual market players are applying biotechnological advancements in a bid to satisfy both current regulations and international/client demands.

GLOBAL CRISES IMPACTING BIOSYNTHESIS OF CANNABINOIDS MARKETCOVID-19 IMPACT

Biosynthesis of Cannabinoids Industry Had a Positive Effect Due to Pandemic disruptions during COVID-19

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing Higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic positively impacted the Biosynthesis of Cannabinoids Market as disruptions in traditional cannabis cultivation and supply chains highlighted the need for scalable and reliable production methods. Increased demand for cannabinoids in healthcare, particularly for stress and pain management, accelerated research and investment in biosynthesis technologies. The industry's focus on sustainable, lab-based solutions gained traction, ensuring growth amid pandemic-induced challenges. This shift reinforced the market's resilience and innovation-driven expansion.

LATEST TREND

"Advanced synthetic biology boosts cannabinoid biosynthesis efficiency, driving market growth"

One of the latest trends in the Biosynthesis of Cannabinoids Market is the integration of advanced synthetic biology tools to enhance production efficiency and yield. Companies are increasingly leveraging CRISPR and gene-editing technologies to optimize microbial strains for cannabinoid biosynthesis. This trend reduces production costs while ensuring consistency and scalability, making it a game-changer for the pharmaceutical sector. emphasis on eco-friendly and sustainable production further aligns with global market demands.

BIOSYNTHESIS OF CANNABINOIDS MARKET SEGMENTATION

BY TYPE

Based on Type, the global market can be categorized into THC & CBD

• THC: THC biosynthesis targets synthesizing the mind-altering compound tetrahydrocannabinol in the plant through microbial synthesis. This method remains quality assured and convenient for large-scale productions, a requirement when dealing with medical and recreational marijuana. Increasing use of THC for pain relief treatments and as part of psychiatric medication leads to the improvement of its biosynthesis processes.
• CBD: CBD pays great attention to the synthesis of cannabidiol, a cannabinoid that does not exert psychoactive effects but has multiple pharmaceutical uses. This is why lavender oil is applied in wellness products, in the pharmaceutical industry, and in cosmetics because of the anti-inflammatory, calming effects of this oil, and opportunities of biosynthesis increase in demand while keeping constant the quality and eco-friendliness. and consistent cannabinoid production for pharmaceuticals, cosmetics, and food industries. Growing demand for cannabinoids, coupled with advancements in synthetic biology, propels market expansion. Key players are leveraging biotechnological innovations to cater to regulatory standards and meet global consumer needs.

BY APPLICATION

Based on application, the global market can be categorized into Food Industry & Medical Industry

• Food Industry: Cannabinoids derived from biosynthesis are getting popular in the food industry for functional food and beverages that are helpful in stress and in improving night sleep. It affords accurate and reproducible dosage, and there are no questions raised about having chemical impurities that are suitable for consumer products. Some of the reasons for the increased use of biosynthesis technologies to produce cannabinoids are the increasing demand for infused edibles and beverages. 
• Medical Industry: The medical industry utilizes biosynthesized cannabinoids for their pharmacological effect on specific diseases such as epilepsy, chronic pain, or anxiety. In addition, biosynthesis deals with the issue of higher quality and reproducibility and standpoint on the regulatory aspects and patients’ needs. Development in this technology enhances the adaptation of cannabinoids in pharma formulation and clinical management.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.     

DRIVING FACTORS

"Edible drug demand drives cannabinoid biosynthesis advancements, fueling market growth"

The growing acceptance of edible drugs for health disorders, including epilepsy, anxiety, and pain, has boosted production requirements. This technique of production through biosynthesis meets the pharmaceutical cyclic trends in quality since it is much more scalable and consistent than the cultivation process. This shift is causing unprecedented spending on R&D specifically associated with cannabinoid biosynthesis technologies. 

"Biosynthesis reduces costs, environmental impact, ensuring supply, driving market growth "

Some issues associated with conventional marijuana production include issues to do with water consumption, soil dependency, and many of them are environmentally unfriendly. Biosynthesis answers these questions by providing noble solutions of environmental imprint with lower costs of production. The use of products containing cannabinoids is growing; therefore, using biosynthesis, manufacturers provide for constant supplies while minimizing the effect on the environment and resulting cannabinoids market growth.

RESTRAINING FACTOR

"High costs and legal barriers hinder market growth for cannabinoids"

The challenges affecting the biosynthesis of cannabinoids market include new research and development costs, setting up biosynthesis equipment costs, and product commercialization costs. The costs include costs of screening to acquire steady microbial strains and costs of scaling to make big enough quantities for industrial use; it might bar small performers from operating in the market, hence limiting the number of industry performers. Also, the legal requirements have increased understanding of cannabinoids but restrict their commercialization.

OPPORTUNITY

"Rising demand for sustainable cannabinoid cosmetics fuels market growth"

One of the opportunities in the Biosynthesis of Cannabinoids Market is in the constantly increasing interest in cannabinoid-based cosmetics and SPA products. Since people are in search of natural-oriented remedies for skin treatments, relaxation, and health-promoting effects, biosynthesized cannabinoids provide a stable and renewable source. It also creates a trend for expanding market opportunities for biosynthesis technology in the cosmetic and personal care product market. The rise in sustainability concerns, as well as a shift towards clean label products, also augments this opportunity.

CHALLENGE

"Complex regulations hinder cannabinoid biosynthesis, challenging compliance and market growth"

One of the major threats apparent in the Biosynthesis of Cannabinoids Market is the multifaceted and transformational particularities of the legislative framework concerning the elucidation. That is why legal frameworks and regulatory policies of different countries and regions may pose threats and restrict market entry and extension in the case of cannabinoid production and sales. Some of them impact product approvals and hinder the revenue-generating process, while others raise compliance costs. However, they all coexist and remain a major challenge in the legal landscape for market players.

BIOSYNTHESIS OF CANNABINOIDS MARKET REGIONAL INSIGHTS

• NORTH AMERICA

North America's biotech advancements and demand drive market growth

North America is holding the largest share in the global Biosynthesis of Cannabinoids Market because of the sound R&D, well-developed biotechnology sectors, and the large customer demand. The United States is a significant market, given its vibrant biotech market and rising use of cannabinoids in drugs and healthy living products. The United State biosynthesis of cannabinoids market also has friendly regulatory policies and major funding on the technologies of cannabinoid biosynthesis. These fundamentals sustain the region’s evolution and advancement in the industry, therefore.

• EUROPE

Europe's biotech adoption and green focus boost market growth

The Biosynthesis of Cannabinoids Market is bolstered through Europe’s burgeoning interest in biotechnology and its fairly progressive stance concerning cannabis products. The growth in the region’s pharmaceutical industry indicates the adoption of biosynthesis techniques in rebalancing cannabinoid production quality, efficiency, and scalability. The Germans and Dutch are ahead in terms of regulatory progress and market application. The concept of sustainable and green chemistry is widely accepted in the European continent and therefore calls for environmentally friendly methods of producing cannabinoids.o

• ASIA

Asia's biotech advances and demand drive market growth forward

Asia holds remarkable Cannabinoids Market share through purchasing curiosity and new improvements in biotech and analysis in nations like China, Japan, and India. Most of these countries are putting a lot of effort into the discovery of efficient methods of biosynthesis to respond to the growing demand of cannabinoids in medicine and health products. It is worth mentioning that the greatly populated region offers a consumption market for the cannabinoid-based products. Although the cultures of cannabis consumption are much stricter across the Asian countries, Asia is gradually moving forward to its priority role in the production and development of cannabinoids.

KEY INDUSTRY PLAYERS

"Biotech investments and diverse applications drive market growth"

The market is growing because key industry players are investing in the biotechnology and research for the better biosynthesis of cannabinoids and the development of scalable biosynthetic processes. They further pointed out how their microbial engineering and genetic modification provide eco-friendly and economical options to produce cannabinoids. Also, joint ventures, intense regulatory mechanisms, and diversification of product portfolios in the therapeutic, healthy living, and beauty markets also boost the rate of market growth.

LIST OF TOP BIOSYNTHESIS OF CANNABINOIDS COMPANIES

• Anandia Laboratories (Canada)
• Gingko Bioworks (USA)
• Hyasynth Bio (Canada)
• InMed Pharmaceuticals (Canada)
• Librede (USA)

KEY INDUSTRY DEVELOPMENTS

December 2023: BayMedica, a biotechnology company specializing in cannabinoid production, announced a breakthrough in synthesizing rare cannabinoids from sugars. This innovative approach enables the creation of pure, pharma-grade cannabinoids without the need for traditional plant extraction methods. Dr. Shane Johnson, MD, Senior Vice President and General Manager of BayMedica, highlighted the company's commitment to advancing cannabinoid biosynthesis, offering a more sustainable and efficient alternative to conventional production techniques. 

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The Biosynthesis of Cannabinoids market is poised for a continued boom pushed by increasing health recognition, the growing popularity of plant-based diets, and innovation in product services. Despite challenges, which include confined uncooked fabric availability and better costs, the demand for gluten-unfastened and nutrient-dense alternatives supports marketplace expansion. Key industry players are advancing via technological upgrades and strategic marketplace growth, enhancing the supply and attraction of Biosynthesis of Cannabinoids. As customer choices shift towards healthier and numerous meal options, the Biosynthesis of Cannabinoids market is expected to thrive, with persistent innovation and a broader reputation fueling its destiny prospects.